{
    "organizations": [],
    "uuid": "af2fc192fd7d036f2c6d750f7902bdf57385018e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-jingxin-pharmaceutical-ob/brief-zhejiang-jingxin-pharmaceutical-obtains-high-tech-enterprise-recognition-and-to-enjoy-tax-preference-idUSL4N1P52E6",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Jingxin Pharmaceutical obtains high-tech enterprise recognition and to enjoy tax preference",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10(Reuters) - Zhejiang Jingxin Pharmaceutical Co Ltd\n* Says it was recognized as high-tech enterprise again, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019\nSource text in Chinese: goo.gl/qsoGhS\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-10T14:58:00.000+02:00",
    "crawled": "2018-01-11T12:41:53.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "jingxin",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "recognized",
        "enterprise",
        "enjoy",
        "tax",
        "preference",
        "percent",
        "three",
        "year",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}